Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...
Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...
Everyday Health on MSN

9 Dos and Don'ts Before a PSA Test

Ensure accurate PSA test results with these 9 tips. Learn what to do before a PSA test to improve reliability, including managing medications, exercise, and more.
Hormonal therapies are effective for recurrent and advanced prostate cancer, with PSA levels crucial for risk stratification. Combination hormone therapy is advised for metastatic prostate cancer, ...
During September’s Prostate Cancer Awareness Month, MidLantic Urology is reminding men of a critical point. It's 0.75. If your PSA increases by 0.75 in 1 year, it could be prostate cancer, and it’s ...
To the investigator and clinician, prostate-specific antigen (PSA) level is a seemingly perfect outcome measure because it is easily assessable, quantitative, reproducible, and inexpensive. Whether ...
High pre-treatment PSA levels correlate with increased recurrence and treatment failure in intermediate-risk prostate cancer patients treated with HIFU. Gleason grade 3 or higher is associated with ...
Contrary to recommendations regarding age and PSA screening, over the course of nearly two decades the highest PSA testing ...
Targeting men in the top 10% of genetic risk helped detect high-grade prostate cancer that conventional screening would miss, paving the way for more personalized and effective early detection ...
The former PM is among those in favour of targeted screening for men most at risk, but some medical experts are sceptical.
There is no single, diagnostic test for prostate cancer and PSA tests are not routinely used to screen healthy men because ...
With the backing of Rishi Sunak, Prostate Cancer Research, has published a report to the National Screening Committee in 2022 ...